An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
D001786:Blood Glucose / Q000032:analysis; D002747:Chlorpropamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003510:Cyclohexanes / Q000008:administration & dosage / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D003927:Diet, Diabetic; D005260:Female; D005905:Glyburide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006029:Glycosuria; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010629:Phenformin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011719:Pyrazines / Q000008:administration & dosage / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000627:therapeutic use*
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D011719:Pyrazines; D013453:Sulfonylurea Compounds; D010629:Phenformin; D005905:Glyburide; D002747:Chlorpropamide